Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foragen Technology Ventures was a specialized Canadian venture capital fund dedicated to seed-stage and early-stage investments in the advanced agricultural and life sciences sectors. Based in Guelph, Ontario, the firm operated as a partnership between the Business Development Bank of Canada (BDC) and several major Canadian chartered banks, including RBC, CIBC, and TD. Foragen focused on bridging the gap between academic research and commercialization, targeting innovations in genomics, proteomics, and biotechnology. The fund played a significant role in the Canadian ag-biotech ecosystem during the early 2000s by providing critical early-stage capital to startups. Its portfolio included various companies aimed at improving crop yields, developing novel bio-based products, and advancing human health through biotechnology. The fund has since completed its investment lifecycle and is no longer actively making new investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foragen Technology Ventures.